Cargando…
Venetoclax for treating refractory autoimmune hemolytic anemia in chronic lymphocytic leukemia: report of two cases in Spain
Autores principales: | Galindo-Navarro, Pablo, Delgado-García, Alicia, Rodríguez-Gil, Miguel A., Puerta-Puerta, José M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388283/ https://www.ncbi.nlm.nih.gov/pubmed/36861400 http://dx.doi.org/10.3324/haematol.2022.281850 |
Ejemplares similares
-
Can Treatment with Venetoclax for Chronic Lymphocytic Leukemia (CLL) Result In Autoimmune Hemolytic Anemia?
por: Abdel-Samad, Nizar, et al.
Publicado: (2021) -
A case of chronic lymphocytic leukemia complicated by autoimmune hemolytic
anemia due to ibrutinib treatment
por: Suzuki, Takaharu, et al.
Publicado: (2018) -
Efficacy of eculizumab in refractory life‐threatening warm autoimmune hemolytic anemia associated with chronic myelomonocytic leukemia
por: Gauchy, Anne‐Cécile, et al.
Publicado: (2020) -
Refractory Autoimmune Cytopenias Treated With Venetoclax
por: Gordon, Max J., et al.
Publicado: (2019) -
Autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia
por: Al Hadidi, Samer, et al.
Publicado: (2020)